Actively Recruiting
The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases
Led by University Hospital Olomouc · Updated on 2026-01-27
400
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
Sponsors
U
University Hospital Olomouc
Lead Sponsor
B
Brno University of Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study titled "The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases" investigates the impact of using EIT as a non-invasive method to monitor the distribution of pulmonary ventilation and its relationship to standard spirometry in patients with various lung diseases. The main aim of this study is to investigate new approaches to the assessment of lung status and diagnosis of lung diseases. Unlike spirometry, which has long been a well-known and important diagnostic tool in pulmonary medicine, and which provides valuable information about the volume and flow of inspired and expired air, EIT provides spatial information about the distribution of ventilation in real time and without the need for active patient cooperation. Research and practice have shown that spirometry is problematic in specific groups of patients, such as patients with tracheostomy or facial palsy. The technology should also enable detection of the disease in its early stages, when treatment is most effective. 300 participants in the experimental group and 100 participants in the control group will receive spirometry and electrical impedance tomography independent examination. The primary endpoint of the study is to investigate the potential of EIT in respiratory medicine, specifically identifying the relationship between EIT and traditional spirometry. This effort is motivated by the need for novel noninvasive methods for the diagnosis and monitoring of respiratory diseases, especially in patients unable to undergo conventional spirometry, or in case of interventions requiring real-time feedback. The purpose of the research project in relation to these objectives is to bring new possibilities in the field of diagnosis and monitoring of lung diseases through EIT, which could lead to significant improvements in patient care. Demographic and anthropometric data, including age, sex, body height, body weight, body mass index (BMI), chest circumference, and smoking history will be collected in all participants. These parameters will be used as covariates in the analysis to assess their impact on EIT-derived indicators and to improve normalization of EIT signals. Additionally, the study aims to develop and validate a machine learning model, particularly a deep neural network, capable of predicting standard spirometric parameters (e.g., FEV1, FVC, PEF) based solely on EIT signals. This could allow for an accurate assessment of dynamic pulmonary volumes in cooperating patients who are unable to undergo conventional spirometry (e.g. patients with tracheostomy).
CONDITIONS
Official Title
The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and older
- Diagnosed with chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, pneumonia, or post-COVID-19 pulmonary findings
- Healthy individuals with normal physical exams, no respiratory symptoms, BMI between 18 and 36, and who are non-smokers or ex-smokers abstinent for 12 months or more
- Ability to perform spirometry while seated, except for those in a subgroup where inability to perform spirometry is studied
- Signed informed consent approved by the ethics committee
You will not qualify if you...
- Patients under 18 years of age
- Severe cardiovascular disease
- Pregnancy
- Unable to give informed consent
- Current acute respiratory infection (except those recovering from pneumonia or COVID-19 within the study focus)
- Inability to perform spirometry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Pulmonary Diseases and Tuberculosis, University hospital Olomouc
Olomouc, Czechia, 77900
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here